Check patentability & draft patents in minutes with Patsnap Eureka AI!

Compositions and methods for degradation of misfolded proteins

A technology of misfolding and composition, applied in the field of compositions and methods for degrading misfolded proteins, capable of solving problems such as poor system understanding

Pending Publication Date: 2018-07-10
THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
View PDF29 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, understanding of these systems is still poor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for degradation of misfolded proteins
  • Compositions and methods for degradation of misfolded proteins
  • Compositions and methods for degradation of misfolded proteins

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0240] Formulations of the pharmaceutical compositions herein may be prepared by any method known or hereafter developed in the art of pharmacy. In general, these methods of preparation include the step of bringing into association the active ingredient with the carrier or one or more other accessory ingredients, and then, if necessary or desired, shaping or packaging the product into the desired unit-dose or multi-dose unit.

[0241] As used herein, a "unit dose" is an individual quantity of a pharmaceutical composition containing a predetermined quantity of an active ingredient. The amount of active ingredient is usually equal to the dose of active ingredient to be administered to the subject, or a convenient fraction of the dose, such as for example one-half or one-third of the dose. Unit dosage forms can be for single daily administration or multiple daily administrations (eg, about 1 to 4 or more times per day). When multiple daily doses are used, the unit dosage form ma...

Embodiment 1

[0278] Example 1: A cellular system that degrades misfolded proteins and protects against neurodegeneration

[0279] Misfolded proteins impair cellular function and lead to disease. How these proteins are detected and degraded is not well understood. Experiments presented herein show that PML (also known as TRIM19) and the SUMO-dependent ubiquitin ligase RNF4 work together to promote the degradation of misfolded proteins in the mammalian nucleus. PML selectively interacts with misfolded proteins through distinct substrate recognition sites and binds these proteins to small ubiquitin-like modifiers (SUMOs) through its SUMO ligase activity. The SUMOylated misfolded protein is then recognized and ubiquitinated by RNF4, and the misfolded protein is subsequently targeted for proteasomal degradation. Furthermore, it is shown herein that PML deficiency accelerates polyglutamine (polyQ) disease in a mouse model of spinocerebellar ataxia type 1 (SCA1). These findings reveal a mamm...

Embodiment 2

[0401] Example 2: TRIM proteins can recognize misfolded proteins and promote their degradation

[0402] The triple domain-containing (TRIM) family consists of a large number of proteins in the cells of multicellular animals, ranging from about 20 in C. elegans to over 70 in mice and humans. These proteins share a characteristic TRIM or RBCC motif at their N-termini, which consists of a RING domain, one or two B-boxes (similar to the RING domain, coordinated by zinc ions) and a coiled-coil region. This is followed by a more variable C-terminal region in TRIM proteins and contains different motifs (Hakeyama, 2011, Nat Rev Cancer, 11:792-804; Ozato et al., 2008, Nat Rev Immunol, 8:849 -860). TRIM proteins regulate a range of cellular processes, including those that protect against cancer and viral infection. Biochemically, some TRIM proteins display ubiquitin E3 ligase activity, which is attributed to the RING domain within the TRIM / RBCC region. In addition, at least some TR...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to compositions and methods for promoting the degradation of misfolded proteins and protein aggregates. The compositions and methods may be used to treat a disorder associated with misfolded proteins or protein aggregates. In certain instances, the compositions and methods relate to modulators of one or more TRIM proteins or one or more STUbLs.

Description

[0001] Citations to related applications [0002] This application claims priority to US Provisional Patent Application No. 62 / 168,309, filed May 29, 2015, the contents of which are hereby incorporated by reference in their entirety. [0003] Statement Regarding Federally Sponsored Research or Development [0004] This invention was made with government support under CA088868, GM060911, CA182675, CA184867, and P30AI045008 awarded by the National Institutes of Health. The government has certain rights in this invention. Background technique [0005] Proteins are the most abundant macromolecules of cells and are important for almost all physiological processes. To perform their biological function, most proteins need to fold into and maintain their native conformation. Although the native conformation of a protein is determined by its amino acid sequence, the folding process is complex and highly error-prone, and its application can be further limited by genetic mutations, er...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P11/00A61P25/28G01N33/566G01N33/68
CPCG01N33/5058G01N33/6896G01N2800/2814A61K38/1709A61P11/12A61P25/28C12N15/113A61K48/00C12N2710/10043C12N2310/14C12N7/00A61P25/00A61P25/16A61K39/395A61K2039/505A61K38/21A61P11/00G01N33/566
Inventor 杨小鲁郭骊骊
Owner THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More